Digital Pathology Market Overview:

German Digital Pathology Market was valued at $24 million in 2015, and is expected to reach $58 million by 2022, supported by a CAGR of 12.1% during the forecast period 2016 - 2022. Digital pathology is defined as an image-based information setting enabled by computer technology which allows the management of information generated through a digital slide. Digitalization of pathology has led to the automation of tests during diagnosis, such as a single digital instrument can perform tests that were previously performed by five instruments by pathologists. Digital pathology solutions offer high-resolution sample scanning, scrutiny & analysis of images on a computer and online storage of digital slides, which enable pathologists to cross examine slides without physical evidences.

Growth of the market is mainly attributed to factors such as high efficiency of digital pathology systems, ease of virtual transportation of slides, efficient cost of digital pathology products, and increased efficiency. In addition, higher adoption of digital pathology over conventional pathology treatments further drives the world market.

Get more information on this report : Request Sample Pages

Research Methodology:

For this research report, we conducted about 12 hours of interviews and discussions with a wide range of stakeholders, including upstream and downstream participants. Primary research typically is bulk of our research efforts; however, coherently supported by extensive secondary research. We reviewed over 4,120 product literatures, industry releases, annual reports, and other such documents of key industry participants for better market understanding and competitive intelligence. In addition, authentic industry journals, medical journals, trade associations releases, and government websites have also been reviewed for generating high-value industry insights.

Our primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. We have established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

• Validates and improves the data quality and strengthens research proceeds
• Further develops analyst teams market understanding and expertise
• Supplies authentic information about market size, share, growth, and forecasts

Market Definition And Scope:

Digital pathology gradually replaces the conventional pathology methods. The key reason for the adoption of the digital pathology system is its reduction in cost, fast, and easy delivery of slides. Thus, it helps in efficient analysis of the slide through DPS (digital pathology system). This also includes discussion with other pathologists during analysis.

Digital Pathology, By Product:

The services provided by the manufactures of scanners include high-resolution sample scanners and software to analyze slides and services for slide storage. The systems are available in desktop size, network infrastructure, server, processor, and computers along with 20-inch monitors. The cost of the systems varies from $30,000 to $1 million.

Get more information on this report : Request Sample Pages

Get more information on this report : Request Sample Pages

Key players operating in the market include Visiopharm, Digipath Inc. Koninklinje Philips N. V., PerkinElmer, Inc., Danaher Corporation (Leica Microsystem), Nikon Corporation, Carl Zeiss AG, Definiens AG, VMscope GmbH and microDimensions GmbH. Other players in the value chain include Indica Labs, Hamamatsu Photonics Europe GmbH, Pixcelldata Ltd., Glencoe Software Inc.

Key Benefits

• Competitive landscape section includes major players operating within the digital pathology market, with key strategies adopted by them to achieve high monetary value.
• The report also provides quantitative as well as qualitative trends to assist the stakeholders understand the situations prevailing in the market.
• Entire projections presented in the report are based on analysis of the current trends and highlight the market potential from 2016 to 2022.
• The report provides an in-depth analysis of the estimated revenues generated as well as major geographies during the forecast period. 

Germany Digital Pathology Market Key Segments:

By Product

• Whole Slide Imaging 
• Image Analysis Informatics
• Information Management System Storage & Communication
• Telepathology

By End User

• Educational Institutes
• Hospitals and Diagnostic Centers
• Pharmaceutical & Biotechnology Companies

 Key Market Segments

• By PRODUCT
  • Whole slide imaging (WSI)
  • Image analysis informatics
  • Information management system storage & communication
  • Telepathology
• By END USER
  • Educational institutes
  • Hospitals and diagnostic centers
  • Pharmaceutical and biotechnology companies
• By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Malaysia
    • Indonesia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • UAE
    • Argentina
    • Rest of LAMEA

 
Key Market Players

• Digipath, Inc.
• microDimensions GmbH
• Definiens AG
• VMscope GmbH
• Danaher Corporation (Leica Microsystem)
• PerkinElmer, Inc.
• Carl Zeiss AG
• Nikon Corporation
• Visiopharm
• Koninklijke Philips N.V.

• Indica Labs
• Hamamatsu Photonics Europe GmbH
• Pixcelldata Ltd.
• Glencoe Software Inc.

CHAPTER 1 INTRODUCTION

1.1 Report description
1.1 Key benefits
1.2 Key market segment
1.3 Research methodology

1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top winning strategies

3.3 Conventional pathology vs. digital pathology
3.4 Key player positioning, 2015
3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Use of digital pathology in cancer diagnosis
3.5.1.2 Cost efficiency
3.5.1.3 Ease in transportation
3.5.1.4 High efficiency
3.5.1.5 Efficient analysis
3.5.1.6 System efficiency
3.5.1.7 Efficiency in workflow
3.5.1.8 Diagnosis in remote regions

3.5.2 Restraints

3.5.2.1 Lack of reimbursement
3.5.2.2 Lack of infrastructure in developing economies
3.5.2.3 Resistance towards adoption of digital pathology

3.5.3 Opportunities

3.5.3.1 Rising awareness pertaining to digital pathology
3.5.3.2 Increasing potential of digital pathology

CHAPTER 4 GERMANY DIGITAL PATHOLOGY MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast
4.1.2 Whole slide imaging (WSI)

4.1.2.1 Market size and forecast

4.1.3 Image analysis informatics

4.1.3.1 Market size and forecast

4.1.4 Information management system storage & communication

4.1.4.1 Market size and forecast

4.1.5 Telepathology

4.1.5.1 Market size and forecast

CHAPTER 5 GERMANY DIGITAL PATHOLOGY MARKET, BY END USER

5.1 Overview

5.1.1 Market size and forecast
5.1.2 Educational institutes

5.1.2.1 Market size and forecast

5.1.3 Hospitals and diagnostic centers

5.1.3.1 Market size and forecast

5.1.4 Pharmaceutical and biotechnology companies

5.1.4.1 Market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Danaher Corporation (Leica Microsystem)

6.1.1 Company Overview
6.1.2 Company Snapshot
6.1.3 Operating Business Segments
6.1.4 Business Performance
6.1.5 Key Strategic Moves & Developments

6.2 Definiens AG

6.2.1 Company Overview
6.2.2 Company Snapshot
6.2.3 Business Performance
6.2.4 Key Strategic Moves & Developments

6.3 Carl Zeiss AG

6.3.1 Company Overview
6.3.2 Company Snapshot
6.3.3 Operating Business Segments
6.3.4 Business Performance
6.3.5 Key Strategic Moves and Developments

6.4 VMscope GmbH

6.4.1 Company Overview
6.4.2 Company Snapshot
6.4.3 Operating Business Segments
6.4.4 Business Performance
6.4.5 Key Strategic Moves and Developments

6.5 microDimensions GmbH

6.5.1 Company Overview
6.5.2 Company Snapshot
6.5.3 Operating Business Segments
6.5.4 Business Performance
6.5.5 Key Strategic Moves and Developments

6.6 Visiopharm

6.6.1 Company Overview
6.6.2 Company Snapshot
6.6.3 Operating Business Segments
6.6.4 Business Performance
6.6.5 Key Strategic Moves & Developments

6.7 Koninklijke Philips N.V.

6.7.1 Company Overview
6.7.2 Company Snapshot
6.7.3 Operating Business Segments
6.7.4 Business Performance
6.7.5 Key Strategic Moves & Developments

6.8 PerkinElmer, Inc.

6.8.1 Company Overview
6.8.2 Company Snapshot
6.8.3 Operating Business Segments
6.8.4 Business Performance
6.8.5 Key Strategic Moves & Developments

6.9 Nikon Corporation

6.9.1 Company Overview
6.9.2 Company Snapshot
6.9.3 Operating Business Segments
6.9.4 Business Performance
6.9.5 Key Strategic Moves & Developments

6.10 Digipath, Inc.

6.10.1 Company Overview
6.10.2 Company Snapshot
6.10.3 Operating Business Segments
6.10.4 Key Strategic Moves & Developments

Other players in the value chain include:

• Indica Labs
• Hamamatsu Photonics Europe GmbH
• Pixcelldata Ltd.
• Glencoe Software Inc.

*Profiles of these players are not included. The same will be included on request.

List of Figures

FIG. 1 DATA TRIANGULATION METHODOLOGY
FIG. 2 PRIMARY AND SECONDARY RESEARCH
FIG. 3 INDUSTRY PARTICIPANTS FROM SUPPLY SIDE
FIG. 4 INDUSTRY PARTICIPANTS FROM DEMAND SIDE
FIG. 5 GERMANY DIGITAL PATHOLOGY MARKET, 2015 VS 2022, ($MILLION)
FIG. 6 DIGITAL PATHOLOGY: MARKET DEFINITION
FIG. 7 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION
FIG. 8 TYPES OF STRATEGIES DISTRIBUTION
FIG. 9 DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIG. 10 KEY PLAYER POSITIONING, 2015
FIG. 11 TOP IMPACTING FACTORS: GERMANY DIGITAL PATHOLOGY MARKET (20142022)
FIG. 12 DIGITAL PATHOLOGY: WORKFLOW
FIG. 13 GERMANY: WHOLE SLIDE IMAGING MARKET, 20142022 ($MILLION)
FIG. 14 GERMANY: IMAGE ANALYSIS INFORMATICS MARKET, 20142022 ($MILLION)
FIG. 15 INFORMATION MANAGEMENT SYSTEM STORAGE & COMMUNICATION: STORAGE WORKFLOW
FIG. 16 GERMANY: INFORMATION MANAGEMENT SYSTEM STORAGE & COMMUNICATION MARKET, 20142022 ($MILLION)
FIG. 17 GERMANY: TELEPATHOLOGY MARKET, 20142022 ($MILLION)
FIG. 18 GERMANY: EDUCATIONAL INSTITUTES END USER MARKET, 20142022 ($MILLION)
FIG. 19 GERMANY: HOSPITALS AND DIAGNOSTIC END USER MARKET, 20142022 ($MILLION)
FIG. 20 GERMANY: PHARMACEUTICAL & BIOTECHNOLOGY END USER MARKET, 20142022 ($MILLION)
FIG. 21 DANAHER: NET SALES, 20132015 ($MILLION)
FIG. 22 DANAHER: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 23 DANAHER: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 24 DANAHER: STRATEGY SHARE, 20122015 (%)
FIG. 25 DEFINIENS: STRATEGY SHARE, 20142016 (%)
FIG. 26 CARL ZEISS: REVENUE, 20132015 ($MILLION)
FIG. 27 CARL ZEISS: REVENUE, BY SEGMENT, 2015 (%)
FIG. 28 CARL ZEISS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 29 CARL ZEISS: STRATEGY SHARE, 2016 (%)
FIG. 30 VMSCOPE: STRATEGY SHARE, 20132015 (%)
FIG. 31 VISIOPHARM: STRATEGY SHARE, 20142016 (%)
FIG. 32 PHILIPS HEALTHCARE: NET SALES, 20132015 ($MILLION)
FIG. 33 PHILIPS HEALTHCARE: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 34 KONINKLIJKE PHILIPS N. V.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 35 PHILIPS HEALTHCARE: STRATEGY SHARE, 20142016 (%)
FIG. 36 PERKINELMER, INC.: NET SALES, 20132015 ($MILLION)
FIG. 37 PERKINELMER INC.: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 38 PERKINELMER INC.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 39 PERKINELMER INC.: STRATEGY SHARE, 20142016 (%)
FIG. 40 NIKON: NET SALES, 20132015 ($MILLION)
FIG. 41 NIKON: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 42 NIKON: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 43 DIGIPATH: STRATEGY SHARE, 20132014 (%)

List of Table

TABLE 1 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20142022 ($MILLION)
TABLE 2 GERMANY: WHOLE SLIDE IMAGING MARKET, 20142022 ($MILLION)
TABLE 3 GERMANY: IMAGE ANALYSIS INFORMATICS MARKET, 20142022 ($MILLION)
TABLE 4 GERMANY: INFORMATION MANAGEMENT SYSTEM STORAGE & COMMUNICATION MARKET, 20142022 ($MILLION)
TABLE 5 GERMANY: TELEPATHOLOGY MARKET, 20142022 ($MILLION)
TABLE 6 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 20142022 ($MILLION)
TABLE 7 GERMANY: EDUCATIONAL INSTITUTES END USER MARKET, 20142022 ($MILLION)
TABLE 8 GERMANY: HOSPITALS & DIAGNOSTIC CENTERS END USER MARKET, 20142022 ($MILLION)
TABLE 9 GERMANY: PHARMACEUTICAL & BIOTECHNOLOGY END USER MARKET, 20142022 ($MILLION)
TABLE 10 DANAHER: COMPANY SNAPSHOT
TABLE 11 DANAHER: OPERATING SEGMENTS
TABLE 12 DEFINIENS: COMPANY SNAPSHOT
TABLE 13 CARL ZEISS: COMPANY SNAPSHOT
TABLE 14 CARL ZEISS: OPERATING SEMENTS
TABLE 15 VMSCOPE: COMPANY SNAPSHOT
TABLE 16 VMSCOPE: OPERATING SEGMENT
TABLE 17 MICRODIMENSIONS GMBH: COMPANY SNAPSHOT
TABLE 18 MICRODIMENSIONS: OPERATING SEGMENT
TABLE 19 VISIOPHARM: COMPANY SNAPSHOT
TABLE 20 VISIOPHARM: OPERATING SEGMENTS
TABLE 21 KONINKLIJKE PHILIPS N. V.: COMPANY SNAPSHOT
TABLE 22 PHILIPS HEALTHCARE: OPERATING SEGMENTS
TABLE 23 PERKINELMER INC.: COMPANY SNAPSHOT
TABLE 24 PERKINELMER INC.: OPERATING SEGMENTS
TABLE 25 NIKON: COMPANY SNAPSHOT
TABLE 26 NIKON: OPERATING SEGMENTS
TABLE 27 DIGIPATH, INC: COMPANY SNAPSHOT
TABLE 28 DIGIPATH: OPERATIN